| |
| |
|
| Insider
Information: |
Boger Kenneth S |
| Relationship: |
SVP & Chief Legal Offi... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
112,999 |
|
|
Indirect Shares
|
179,188 |
|
|
| Direct
Value |
$45,321,639 |
|
|
|
Indirect Value
|
$71,868,723 |
|
|
| Total
Shares |
292,187 |
|
|
| Total
Value |
$117,190,362 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
SVP & Chief Legal Offi... |
2011-09-13 |
112,999 |
2011-09-13 |
179,188 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Legal Officer |
• – – |
2011-09-13 |
4 |
AS |
$50.00 |
$1,100,000 |
D/D |
(22,000) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Legal Officer |
• – – |
2011-09-13 |
4 |
OE |
$18.75 |
$412,500 |
D/D |
22,000 |
134,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-07-29 |
4 |
AS |
$50.00 |
$366,700 |
D/D |
(7,334) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-07-29 |
4 |
OE |
$18.75 |
$137,513 |
D/D |
7,334 |
120,333 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-07-20 |
4 |
OE |
$18.75 |
$137,494 |
D/D |
7,333 |
120,332 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-07-20 |
4 |
AS |
$50.04 |
$366,943 |
D/D |
(7,333) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-07-13 |
4 |
AS |
$51.92 |
$380,781 |
D/D |
(7,334) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-07-13 |
4 |
OE |
$18.75 |
$137,513 |
D/D |
7,334 |
120,333 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-07-06 |
4 |
AS |
$50.29 |
$368,949 |
D/D |
(7,333) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-07-06 |
4 |
OE |
$18.75 |
$137,494 |
D/D |
7,333 |
120,332 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-06-29 |
4 |
OE |
$18.75 |
$137,513 |
D/D |
7,334 |
120,333 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-06-29 |
4 |
AS |
$50.64 |
$376,797 |
D/D |
(7,334) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-06-28 |
4 |
AS |
$50.00 |
$733,350 |
D/D |
(14,667) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-06-28 |
4 |
OE |
$18.75 |
$275,006 |
D/D |
14,667 |
127,666 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-06-08 |
4 |
OE |
$18.75 |
$137,494 |
D/D |
7,333 |
120,332 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-06-08 |
4 |
AS |
$53.38 |
$391,436 |
D/D |
(7,333) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-06-01 |
4 |
OE |
$18.75 |
$137,513 |
D/D |
7,334 |
120,333 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-06-01 |
4 |
AS |
$53.59 |
$393,634 |
D/D |
(7,334) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-05-25 |
4 |
AS |
$55.56 |
$227,575 |
D/D |
(4,066) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-05-02 |
4 |
AS |
$55.57 |
$278,460 |
D/D |
(5,000) |
116,752 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-05-02 |
4 |
OE |
$24.66 |
$123,300 |
D/D |
5,000 |
121,752 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-03-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(33,333) |
174,167 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-02-03 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
116,752 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2010-02-04 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
106,023 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2009-07-28 |
4 |
OE |
$10.41 |
$353,550 |
D/D |
19,898 |
115,755 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
